Financial Performance - The company's operating revenue for 2024 was approximately ¥4.01 billion, a decrease of 0.67% compared to ¥4.04 billion in 2023[19]. - The net profit attributable to shareholders for 2024 was approximately ¥247.65 million, representing a significant increase of 176.52% from ¥89.56 million in 2023[19]. - The net cash flow from operating activities increased by 51.85% to approximately ¥584.97 million in 2024, compared to ¥427.74 million in 2023[19]. - The basic earnings per share for 2024 was ¥0.2238, up 179.05% from ¥0.0776 in 2023[19]. - The total assets at the end of 2024 were approximately ¥4.13 billion, a decrease of 8.66% from ¥4.52 billion at the end of 2023[19]. - The company achieved operating revenue of 4,008.78 million yuan, a year-on-year decrease of 0.67%[52]. - The net profit attributable to shareholders increased by 176.52% to 247.65 million yuan[52]. - The revenue from the NdFeB segment was ¥2.12 billion, accounting for 52.79% of total revenue, down 4.85% from the previous year[64]. - The electric motor series revenue increased by 9.14% to ¥898.74 million, representing 22.42% of total revenue[64]. - The electric wheelchair and mobility vehicle segment saw a revenue increase of 10.28% to ¥598.60 million, making up 14.93% of total revenue[64]. Business Strategy and Focus - The company has undergone a change in its main business focus from brown corundum to neodymium iron boron magnetic materials since 2004, and further expanded to include motor series products in 2015[17]. - The company aims to become the leading supplier of neodymium iron boron magnetic materials in China, focusing on green and environmentally friendly sectors such as new energy vehicles and wind power generation[99]. - The company plans to enhance its capital operation capabilities and accelerate international expansion as part of its future development strategy[98]. - The company is targeting to become a first-class provider of efficient power solutions, focusing on drive motors and related components[100]. - The health equipment segment aims to become the top brand in health mobility in China, with plans to expand product categories and enhance market share through both domestic and international channels[101]. Research and Development - The company has received multiple awards for its R&D projects, including the first prize for the "High Stability Neodymium-Iron-Boron Rare Earth Reduction Technology" in Zhejiang Province[47]. - The company has applied for 207 new patents and received 229 new patent authorizations during the reporting period[50]. - R&D investment amounted to ¥194,880,481.61 in 2024, a slight increase of 0.09% compared to ¥194,707,954.37 in 2023, representing 4.86% of operating revenue[76]. - The number of R&D personnel decreased by 1.78% to 881 in 2024 from 897 in 2023, with a notable increase in master's degree holders by 28.13%[76]. - The company is continuously enhancing its research and development capabilities to meet core customer demands and improve delivery efficiency[102]. Environmental and Social Responsibility - The company has a commitment to environmental and social responsibility as outlined in its annual report[5]. - The company invested approximately 13.65 million yuan in environmental governance and protection in 2024[178]. - The company received new pollutant discharge permits for its subsidiaries, valid until 2029[173]. - The total wastewater discharged by the company in 2024 was approximately 80,000 tons, with all monitoring data indicating compliance with discharge standards[175]. - The company implemented measures to reduce carbon emissions by utilizing solar photovoltaic energy[179]. - The company emphasizes social responsibility by promoting green development and contributing to local employment[181]. Corporate Governance - The company has established a complete and independent asset structure, including independent production facilities and intellectual property rights[125]. - The company maintains an independent financial department with a complete accounting system and independent bank accounts[125]. - The board of directors consists of seven members, including three independent directors, meeting legal requirements[120]. - The company has implemented a robust internal control system and governance structure, complying with relevant regulations[124]. - The company actively communicates with stakeholders to balance interests and promote sustainable development[122]. - The company has established various channels for investor communication, enhancing investor relations management[124]. Shareholder and Board Activities - The company plans to distribute a cash dividend of 1.24 RMB per 10 shares to all shareholders, based on a total of 1,097,380,974 shares[4]. - The company held its annual general meeting on April 11, 2024, with an investor participation rate of 41.28%[127]. - The first extraordinary general meeting of 2024 took place on September 5, 2024, with a participation rate of 41.40%[127]. - The second extraordinary general meeting of 2024 is scheduled for December 24, 2024, with a participation rate of 3.54%[128]. - The company reported a total shareholding of 120,617 shares, with an increase of 120,617 shares due to the employee stock ownership plan[130]. Market Trends and Opportunities - The production of neodymium-iron-boron magnets in China reached 280,000 tons in 2024, reflecting a year-on-year growth of 12%[29]. - The production of new energy vehicles in China reached 12.89 million units in 2024, marking a year-on-year increase of 34.4%[30]. - The demand for micro motors in the home appliance sector is expected to exceed 2.42 billion units in 2024, with a year-on-year growth of 6.5%[31]. - The global humanoid robot market is projected to reach $15.1 billion by 2030, with a CAGR exceeding 56% from 2024 to 2030[32]. - The proportion of the global population aged 65 and above is expected to rise to 14.3% by 2040 and 16.3% by 2050, creating structural opportunities for health equipment[33]. Risk Management - The company faces risks from macroeconomic policy changes, intensified industry competition, raw material price fluctuations, and potential loss of core technical personnel[107][108][110]. - The company will actively manage exchange rate risks due to its export business, utilizing financial tools to mitigate potential impacts[111]. - The company is focused on maintaining stable relationships with suppliers to manage raw material costs effectively[108]. Employee Management - The total number of employees at the end of the reporting period was 5,244, including 187 at the parent company and 5,057 at major subsidiaries[152]. - The employee training program includes new employee orientation, professional skills training, and safety education training[155]. - The company has established a comprehensive salary structure based on job categories and performance, including monthly salaries, benefits, and year-end bonuses[154]. - The company has a total of 334 retired employees who require financial support[153]. Compliance and Legal Matters - The company has not faced any penalties from securities regulatory agencies for directors and supervisors in the past three years[140]. - The company has not reported any penalties or rectification issues during the reporting period[196]. - The integrity status of the company and its controlling shareholders remains good, with no significant debts unpaid[197].

和信审字（2025）第 000226 号 目 录 页 码 英洛华科技股份有限公司 内部控制审计报告 一、内部控制审计报告 1-2 和信会计师事务所（特殊普通合伙） 二○二五年三月六日 英洛华科技股份有限公司 报告正文 内部控制审计报告 和信审字(2025)第 000226 号 英洛华科技股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了英洛华科技股份有限公司（以下简称贵公司）2024 年 12 月 31 日的财务 报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制 评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是贵公司董 事会的责任。 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。此外，由于 情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降低， 根据内部控制审计结果推测未来内部控制的有效性具有一 ...

关于英洛华科技股份有限公司 非经营性资金占用及其他关联方资金往来情况的专项说明 和信专字（2025）第000021号 | 目 录 | 页 码 | | --- | --- | | 一、关于英洛华科技股份有限公司非经营性资金占用 | 1-2 | | 及其他关联方资金往来情况的专项说明 | | | 二、英洛华科技股份有限公司 2024 年度非经营性 | 3 | | 资金占用及其他关联方资金往来情况汇总表 | | 和信会计师事务所（特殊普通合伙） 二○二五年三月六日 关于英洛华科技股份有限公司非经营性占用及其他关联方资金往来情况的专项说明 报告正文 关于英洛华科技股份有限公司 非经营性资金占用及其他关联方资金往来情况的 专项说明 和信会计师事务所（特殊普通合伙） 第 1页共 3 页 关于英洛华科技股份有限公司非经营性占用及其他关联方资金往来情况的专项说明 报告正文 本专项说明仅供披露英洛华 2024 年度非经营性资金占用及其他关联方资金 往来情况使用，不得用作其他任何目的。 附件：2024 年度非经营性资金占用及其他关联方资金往来情况汇总表 和信专字（2025）第 000021 号 英洛华科技股份有限公司全体股东： ...

英洛华科技股份有限公司 审计报告 和信审字（2025）第 000225 号 | 目 录 | 页 码 | | --- | --- | | 一、审计报告 | 1-4 | | 二、已审财务报表及附注 | | | 1、合并及公司资产负债表 | 5-8 | | 2、合并及公司利润表 | 9-10 | | 3、合并及公司现金流量表 | 11-12 | | 4、合并及公司股东权益变动表 | 13-16 | | 5、财务报表附注 | 17-100 | 和信会计师事务所（特殊普通合伙） 二○二五年三月六日 英洛华科技股份有限公司 报告正文 审 计 报 告 和信审字(2025)第 000225 号 英洛华科技股份有限公司全体股东： 一、审计意见 我们审计了英洛华科技股份有限公司（以下简称"英洛华"）财务报表，包括 2024 年 12 月 31 日的合并及公司资产负债表，2024 年度的合并及公司利润表、合 并及公司现金流量表、合并及公司股东权益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制， 公允反映了英洛华 2024 年 12 月 31 日合并及公司的财务状况以及 2024 年度 ...

英洛华科技股份有限公司董事会 关于独立董事独立性自查情况的专项意见 根据中国证券监督管理委员会《上市公司独立董事管理办法》《深圳证券交 易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》等要求，英洛华科技股份有限公司（以下简称"公司"）董事 会对公司现任独立董事韩灵丽、闫阿儒、杨庆的独立性情况进行评估并出具如下 专项意见： 经核查独立董事韩灵丽、闫阿儒、杨庆的任职经历及其签署的相关自查文件， 上述人员未在公司担任除独立董事外的任何职务，也未在公司主要股东公司担任 任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立 客观判断的关系，不存在影响独立董事独立性的情况，符合《上市公司独立董事 管理办法》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规 范运作》中对独立董事独立性的相关要求。 英洛华科技股份有限公司董事会 二〇二五年三月六日 ...

英洛华科技股份有限公司 独立董事2024年度述职报告 韩灵丽，英洛华科技股份有限公司（以下简称"公司"）第十届董事会独立 董事。根据 《中华人民共和国公司法》《上市公司治理准则》和《上市公司独立 董事管理办法》等法律法规和《英洛华科技股份有限公司章程》的规定，2024 年度履职情况总结如下： 一、个人履历 韩灵丽，博士研究生，法学教授，具有律师资格和注册税务师资格。曾任浙 江财经大学法学院副院长、院长，浙江财经大学经济与社会发展研究院院长。学 术兼职：中国财税法学研究会常务理事、中国经济法学研究会理事、浙江法学会 理事。其他上市公司独立董事任职：杭州和泰机电股份有限公司独立董事，湘财 股份有限公司独立董事，江潮电机科技股份有限公司（拟上市）独立董事。2021 年 9 月至今，担任公司独立董事。 报告期内，本人任职符合《上市公司独立董事管理办法》第六条所述独立性 和任职不超过三家上市公司的要求，并能本着向公司全体股东负责的原则，忠实、 勤勉尽责，独立履职。 2024 年，本人通过出席股东大会、董事会、战略委员会、审计委员会、薪 酬与考核委员会、提名委员会、独立董事专门会议和实地调研等方式，定期不定 期获取公司生 ...

证券代码：000795 证券简称：英洛华 公告编号：2025-012 英洛华科技股份有限公司 关于回购股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 本次回购符合公司既定回购方案以及相关法律法规的要求。 二、其他说明 公司回购股份的时间、回购股份的数量、回购股份价格及集中竞价交易的委 托时段均符合《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指 引第 9 号——回购股份》及公司回购股份方案的相关规定。 1 1、公司未在下列期间内回购公司股份： 英洛华科技股份有限公司（以下简称"公司"）于 2024 年 3 月 27 日召开第 九届董事会第二十次会议，审议通过了《公司关于回购股份方案的议案》。公司 拟使用自有资金人民币 0.8 亿元-1.6 亿元以集中竞价交易或其他法律法规允许 的方式回购部分公司股份，回购股份价格不超过人民币 7.9 元/股，具体回购股 份的数量以回购期限届满或者回购股份实施完毕时实际回购的股份数量为准。回 购期限为自董事会审议通过回购股份方案之日起 12 个月内。具体内容详见公司 于 2024 年 3 月 28 日、 ...

Group 1: Company Overview - The company operates in four main business segments: magnetic materials, electric motors, health equipment, and electronic acoustics, with magnetic materials accounting for nearly 60% of revenue, electric motors over 20%, and health equipment close to 20% [1]. Group 2: Magnetic Materials - The current production capacity for magnetic materials is approximately 13,000 tons, with a utilization rate of around 70-80%. The company plans to enhance capacity through equipment upgrades and production line modifications, with further expansion considered based on market demand [1][2]. - The magnetic materials are primarily used in smart home appliances, automotive applications, high-end audio systems, and energy-saving elevators [2]. Group 3: Electric Motors - The electric motor segment serves various applications, including health mobility, smart home, garden machinery, security systems, and smart logistics. The company aims to improve profit margins through R&D innovation, process enhancement, and optimization of product and customer structures [2][3]. - New facilities and equipment investments are expected to support the future growth of the electric motor business [2]. Group 4: Health Equipment - The health equipment segment focuses on products like electric wheelchairs and mobility scooters, primarily made from iron, aluminum, carbon fiber, and magnesium alloys, targeting the mid-to-high-end market. Sales channels include major online platforms in China, while overseas sales are mainly through ODM and OEM [3]. - The company plans to expand its product range and enhance product features in response to increasing consumer acceptance and demand due to aging populations and rising living standards [3].

证券代码：000795 证券简称：英洛华 公告编号：2025-011 英洛华科技股份有限公司 关于回购股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 英洛华科技股份有限公司（以下简称"公司"）于 2024 年 3 月 27 日召开第 九届董事会第二十次会议，审议通过了《公司关于回购股份方案的议案》。公司 拟使用自有资金人民币 0.8 亿元-1.6 亿元以集中竞价交易或其他法律法规允许 的方式回购部分公司股份，回购股份价格不超过人民币 7.9 元/股，具体回购股 份的数量以回购期限届满或者回购股份实施完毕时实际回购的股份数量为准。回 购期限为自董事会审议通过回购股份方案之日起 12 个月内。具体内容详见公司 于 2024 年 3 月 28 日、2024 年 4 月 2 日在《中国证券报》《证券时报》和指定 信息披露网站(http://www.cninfo.com.cn)披露的《公司关于回购股份方案的公 告》（公告编号：2024-020）、《公司回购股份报告书》（公告编号：2024-022）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自 ...

Financial Performance - The net profit attributable to shareholders for 2024 is expected to be between 24,000 and 27,000 million yuan, representing a year-on-year increase of 167.98% to 201.48% compared to 8,955.94 million yuan in the previous year[3]. - The net profit after deducting non-recurring gains and losses is projected to be between 18,500 and 22,000 million yuan, reflecting a growth of 47.39% to 75.28% from 12,551.33 million yuan in the same period last year[3]. - Basic earnings per share are anticipated to be between 0.2169 and 0.2440 yuan per share, up from 0.0802 yuan per share in the previous year[3]. Business Development - The increase in performance is attributed to the optimization of internal management in the magnetic materials sector and the stable growth in the health equipment sector through enhanced customer collaboration and product structure optimization[5][6]. - The company signed a share transfer agreement in November 2024 to acquire 100% of Zhejiang Quanfao Technology Co., Ltd., which will be included in the consolidated financial statements for 2024[3]. Investment Risks - The performance forecast has not been audited by registered accountants, and investors are advised to pay attention to investment risks[7].